CABERGOLINE

CABERGOLINE was reported 4924 times

CABERGOLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 60 0.8571
1 CEREBROSPINAL FLUID RHINORRHOEA 25 0.7576
2 TESTOTOXICOSIS 7 0.7000
3 RADIATION INFLAMMATION 39 0.4875
4 CHIASMA SYNDROME 7 0.4375
5 URETHRAL CARUNCLE 18 0.2687
6 ANDROPAUSE 12 0.2308
7 PITUITARY APOPLEXY 30 0.1705
8 MEDIASTINAL FIBROSIS 7 0.1667
9 CAROTID ANEURYSM RUPTURE 6 0.1622
10 ADJACENT SEGMENT DEGENERATION 4 0.1600
11 HEMIANOPIA HETERONYMOUS 13 0.1512
12 GLUCOSE TOLERANCE DECREASED 6 0.1463
13 BLOOD GROWTH HORMONE INCREASED 78 0.1398
14 VISUAL PATHWAY DISORDER 22 0.1366
15 PERFORMANCE ENHANCING PRODUCT USE 13 0.1313
16 PROLACTIN-PRODUCING PITUITARY TUMOUR 23 0.1168
17 PITUITARY HAEMORRHAGE 36 0.1161
18 PROLACTINOMA 15 0.1154
19 PNEUMOCEPHALUS 38 0.1148
20 PRODUCT ADMINISTRATION ISSUE 21 0.1005
21 EMPTY SELLA SYNDROME 21 0.0963
22 CEREBROSPINAL FISTULA 8 0.0860
23 CORTISOL FREE URINE INCREASED 5 0.0746
24 BLOOD PROLACTIN DECREASED 13 0.0743
25 SECONDARY HYPOGONADISM 23 0.0697
26 MITRAL VALVE SCLEROSIS 12 0.0694
27 INSULIN-LIKE GROWTH FACTOR DECREASED 35 0.0662
28 BLOOD GROWTH HORMONE ABNORMAL 8 0.0656
29 HEART VALVE INSUFFICIENCY 8 0.0630
30 INSULIN-LIKE GROWTH FACTOR INCREASED 86 0.0603
31 ACROMEGALY 19 0.0599
32 CEREBROSPINAL FLUID LEAKAGE 108 0.0584
33 PITUITARY TUMOUR RECURRENT 10 0.0575
34 CARDIAC VALVE SCLEROSIS 4 0.0556
35 PROGNATHISM 5 0.0532
36 INSULIN-LIKE GROWTH FACTOR ABNORMAL 6 0.0531
37 LUPUS PNEUMONITIS 5 0.0446
38 BODY HEIGHT ABNORMAL 5 0.0431
39 POSTPRANDIAL HYPOGLYCAEMIA 8 0.0428
40 PULMONARY PAIN 118 0.0404
41 PITUITARY ENLARGEMENT 8 0.0392
42 JEALOUS DELUSION 11 0.0389
43 BILIRUBINURIA 4 0.0381
44 CAROTID ARTERY ATHEROMA 4 0.0377
45 CAMPTOCORMIA 8 0.0333
46 DOPAMINE DYSREGULATION SYNDROME 14 0.0314
47 PATHOLOGICAL GAMBLING 52 0.0313
48 BITE 22 0.0304
49 PITUITARY TUMOUR 45 0.0302
50 BLOOD GROWTH HORMONE DECREASED 6 0.0297
51 INTRACRANIAL HYPOTENSION 19 0.0291
52 AORTIC VALVE SCLEROSIS 21 0.0286
53 GENITAL ULCERATION 21 0.0273
54 CORONARY ARTERY DISSECTION 22 0.0256
55 ATROPHIC VULVOVAGINITIS 18 0.0246
56 BLOOD CORTICOTROPHIN INCREASED 7 0.0242
57 AORTIC VALVE INCOMPETENCE 89 0.0209
58 OVARIAN HYPERSTIMULATION SYNDROME 45 0.0193
59 PITUITARY TUMOUR BENIGN 31 0.0190
60 PLEURAL FIBROSIS 19 0.0186
61 LIGHT CHAIN ANALYSIS INCREASED 19 0.0184
62 CORTISOL INCREASED 11 0.0176
63 PERICARDITIS CONSTRICTIVE 7 0.0166
64 BLOOD PROLACTIN INCREASED 76 0.0161
65 ENCEPHALOCELE 4 0.0161
66 HYPERSEXUALITY 29 0.0159
67 CAVERNOUS SINUS THROMBOSIS 4 0.0157
68 GENITAL PAIN 23 0.0156
69 TRICUSPID VALVE DISEASE 6 0.0150
70 IMPULSE-CONTROL DISORDER 30 0.0146
71 ARTERIOVENOUS FISTULA 7 0.0142
72 MITRAL VALVE DISEASE 24 0.0135
73 APRAXIA 20 0.0135
74 SLEEP ATTACKS 6 0.0126
75 PARKINSON'S DISEASE 32 0.0126
76 MASKED FACIES 5 0.0123
77 UTERINE MASS 5 0.0121
78 HEMIANOPIA 12 0.0121
79 CARDIAC VALVE DISEASE 65 0.0114
80 IIIRD NERVE PARALYSIS 9 0.0111
81 STEREOTYPY 10 0.0106
82 SOFT TISSUE SWELLING 6 0.0106
83 CERVICAL POLYP 4 0.0106
84 GAMBLING 12 0.0103
85 ROOT CANAL INFECTION 5 0.0101
86 PLEUROTHOTONUS 9 0.0100
87 BORDERLINE PERSONALITY DISORDER 7 0.0099
88 COMPULSIVE SHOPPING 20 0.0097
89 MITRAL VALVE INCOMPETENCE 102 0.0090
90 ADRENOCORTICAL INSUFFICIENCY ACUTE 17 0.0087
91 SYNDACTYLY 7 0.0084
92 CEREBRAL ARTERY STENOSIS 4 0.0082
93 BLOOD SODIUM INCREASED 22 0.0081
94 GAMBLING DISORDER 22 0.0081
95 AORTIC VALVE DISEASE 13 0.0081
96 HYPOGONADISM 8 0.0079
97 CORTISOL DECREASED 9 0.0079
98 BLOOD CHLORIDE DECREASED 20 0.0077
99 DILATATION ATRIAL 9 0.0077
100 HAEMOPERITONEUM 6 0.0075
101 BLOOD TESTOSTERONE INCREASED 16 0.0074
102 LIBIDO INCREASED 15 0.0074
103 VITAMIN B12 DECREASED 21 0.0073
104 HYDROTHORAX 6 0.0072
105 SCIATIC NERVE INJURY 6 0.0072
106 BLOOD PARATHYROID HORMONE INCREASED 21 0.0072
107 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 14 0.0071
108 ADENOMA BENIGN 6 0.0070
109 BLOOD PHOSPHORUS INCREASED 19 0.0070
110 TRICUSPID VALVE INCOMPETENCE 55 0.0069
111 HYPOTHALAMO-PITUITARY DISORDER 10 0.0069
112 PERSECUTORY DELUSION 17 0.0068
113 HYPERPROLACTINAEMIA 44 0.0068
114 BRAIN HERNIATION 20 0.0067
115 FOETAL HEART RATE DECREASED 4 0.0064
116 BLOOD CORTISOL DECREASED 4 0.0063
117 EXCESSIVE GRANULATION TISSUE 5 0.0062
118 TWIN PREGNANCY 5 0.0059
119 HORMONE LEVEL ABNORMAL 28 0.0057
120 SYSTOLIC DYSFUNCTION 6 0.0057
121 NEUROENDOCRINE TUMOUR 8 0.0056
122 CATARRH 5 0.0055
123 FIBROSIS 17 0.0055
124 PRIAPISM 19 0.0055
125 HYPOPITUITARISM 9 0.0052
126 GROIN ABSCESS 6 0.0051
127 SUDDEN ONSET OF SLEEP 7 0.0050
128 ENDOMETRIAL HYPERPLASIA 4 0.0049
129 VESTIBULAR DISORDER 6 0.0049
130 OBESITY 78 0.0049
131 FOOD POISONING 26 0.0048
132 PULMONARY VALVE INCOMPETENCE 7 0.0048
133 TEETH BRITTLE 5 0.0048
134 HEPATIC INFECTION 6 0.0047
135 INNER EAR DISORDER 5 0.0047
136 BLOOD PROLACTIN ABNORMAL 4 0.0046
137 PREMATURE SEPARATION OF PLACENTA 7 0.0045
138 SOFT TISSUE DISORDER 5 0.0045
139 KOUNIS SYNDROME 10 0.0044
140 DENGUE FEVER 10 0.0044
141 AKINESIA 9 0.0043
142 OPTIC NERVE INJURY 5 0.0043
143 ECHOCARDIOGRAM ABNORMAL 6 0.0043
144 KNEE ARTHROPLASTY 89 0.0042
145 DIABETES INSIPIDUS 10 0.0041
146 PROTEIN URINE PRESENT 20 0.0040
147 HAEMATOCRIT INCREASED 9 0.0039
148 LIMB DEFORMITY 6 0.0038
149 BLOOD SODIUM ABNORMAL 4 0.0038
150 HIRSUTISM 5 0.0038
151 BODY MASS INDEX INCREASED 5 0.0037
152 BODY TEMPERATURE DECREASED 36 0.0037
153 HEAD TITUBATION 5 0.0036
154 VITREOUS HAEMORRHAGE 10 0.0036
155 HIGH DENSITY LIPOPROTEIN DECREASED 12 0.0036
156 AUTOIMMUNE THYROIDITIS 13 0.0034
157 PSYCHOTIC SYMPTOM 7 0.0034
158 UTERINE POLYP 6 0.0033
159 PEPTIC ULCER 11 0.0033
160 TORTICOLLIS 7 0.0033
161 ADRENAL INSUFFICIENCY 40 0.0033
162 EYE ALLERGY 5 0.0032
163 VISUAL FIELD DEFECT 23 0.0032
164 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
165 PANIC DISORDER 12 0.0031
166 PERSONALITY DISORDER 8 0.0031
167 SCHIZOPHRENIA 37 0.0030
168 FEELING GUILTY 4 0.0030
169 BLOOD PRESSURE SYSTOLIC INCREASED 58 0.0030
170 WEIGHT ABNORMAL 7 0.0029
171 SERUM FERRITIN DECREASED 5 0.0029
172 DILATATION VENTRICULAR 6 0.0029
173 CARDIOMEGALY 35 0.0028
174 DELUSION 44 0.0028
175 HEART VALVE INCOMPETENCE 8 0.0028
176 BLOOD TESTOSTERONE DECREASED 19 0.0028
177 LABYRINTHITIS 7 0.0028
178 NORMAL NEWBORN 15 0.0028
179 ABORTION 8 0.0027
180 CEREBELLAR SYNDROME 6 0.0027
181 HEPATOSPLENOMEGALY 7 0.0027
182 SLEEP APNOEA SYNDROME 52 0.0027
183 HYPOMANIA 10 0.0027
184 LOWER RESPIRATORY TRACT INFECTION 123 0.0027
185 AXILLARY PAIN 4 0.0027
186 DYSENTERY 5 0.0027
187 THYROID MASS 10 0.0026
188 ARTHROPATHY 138 0.0025
189 EAR HAEMORRHAGE 5 0.0025
190 MAJOR DEPRESSION 18 0.0025
191 POSTURE ABNORMAL 8 0.0025
192 TUMOUR HAEMORRHAGE 7 0.0025
193 BREAST ENLARGEMENT 8 0.0024
194 DRUG RESISTANCE 62 0.0024
195 CHOLELITHIASIS 78 0.0024
196 OPTIC NEUROPATHY 5 0.0024
197 NEOPLASM 27 0.0023
198 UTERINE HAEMORRHAGE 10 0.0023
199 CARDIAC MURMUR 20 0.0023
200 GASTROINTESTINAL PAIN 25 0.0023
201 FAECES PALE 5 0.0022
202 NEOPLASM PROGRESSION 78 0.0022
203 IDIOPATHIC INTRACRANIAL HYPERTENSION 5 0.0022
204 BILE DUCT STONE 7 0.0022
205 GOITRE 9 0.0022
206 BRAIN NEOPLASM 20 0.0022
207 POLYP 14 0.0021
208 MENINGITIS 14 0.0021
209 NOCTURIA 25 0.0021
210 MUSCLE RUPTURE 8 0.0021
211 OVERWEIGHT 11 0.0020
212 GALACTORRHOEA 13 0.0020
213 BLOOD IRON DECREASED 24 0.0020
214 PLEURISY 12 0.0020
215 HYDROCEPHALUS 11 0.0020
216 INTRAVENTRICULAR HAEMORRHAGE 5 0.0020
217 HYPERPHAGIA 8 0.0020
218 NERVE INJURY 22 0.0020
219 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
220 DIASTOLIC DYSFUNCTION 6 0.0019
221 LIPOMA 5 0.0019
222 ORTHOPNOEA 6 0.0019
223 SUBCUTANEOUS ABSCESS 9 0.0019
224 AREFLEXIA 5 0.0019
225 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
226 OBSESSIVE-COMPULSIVE DISORDER 15 0.0019
227 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
228 RIGHT VENTRICULAR FAILURE 13 0.0019
229 ABDOMINAL RIGIDITY 5 0.0018
230 HEPATIC STEATOSIS 34 0.0018
231 THYROID NEOPLASM 5 0.0018
232 ON AND OFF PHENOMENON 10 0.0018
233 NEUROLEPTIC MALIGNANT SYNDROME 21 0.0018
234 PETIT MAL EPILEPSY 9 0.0018
235 BLOOD PRESSURE DIASTOLIC DECREASED 13 0.0018
236 DISLOCATION OF VERTEBRA 4 0.0018
237 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
238 TACHYPHRENIA 6 0.0017
239 BLOOD CHOLESTEROL ABNORMAL 8 0.0017
240 DRUG ABUSE 144 0.0017
241 SELF-MEDICATION 7 0.0017
242 LOGORRHOEA 6 0.0017
243 THYROID DISORDER 26 0.0017
244 PRODUCT SUPPLY ISSUE 12 0.0017
245 CEREBROVASCULAR DISORDER 5 0.0017
246 TONGUE DISORDER 12 0.0017
247 IRRITABLE BOWEL SYNDROME 35 0.0016
248 PULMONARY HYPERTENSION 34 0.0016
249 PSYCHIATRIC SYMPTOM 12 0.0016
250 CARTILAGE INJURY 4 0.0016
251 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
252 ACUTE PSYCHOSIS 4 0.0016
253 IMPULSIVE BEHAVIOUR 6 0.0016
254 HYPERGLYCAEMIA 58 0.0016
255 MUSCLE RIGIDITY 19 0.0016
256 DYSLIPIDAEMIA 8 0.0016
257 ANGLE CLOSURE GLAUCOMA 4 0.0016
258 HALLUCINATION, VISUAL 33 0.0016
259 VENTRICULAR HYPOKINESIA 5 0.0016
260 BLOOD UREA INCREASED 26 0.0016
261 BLOOD POTASSIUM INCREASED 25 0.0015
262 PROCEDURAL HAEMORRHAGE 6 0.0015
263 HALLUCINATION, AUDITORY 24 0.0015
264 FEELING OF DESPAIR 7 0.0015
265 UMBILICAL HERNIA 7 0.0015
266 ARTERIOSPASM CORONARY 6 0.0015
267 BREAST SWELLING 4 0.0015
268 NEEDLE ISSUE 43 0.0015
269 CHONDROPATHY 4 0.0015
270 PULMONARY MASS 22 0.0015
271 NEOPLASM RECURRENCE 5 0.0015
272 DIFFICULTY IN WALKING 5 0.0015
273 LEFT VENTRICULAR FAILURE 5 0.0015
274 STILLBIRTH 7 0.0014
275 DIABETIC COMA 4 0.0014
276 INTENTIONAL PRODUCT MISUSE 125 0.0014
277 HALLUCINATIONS, MIXED 6 0.0014
278 MUSCLE FATIGUE 6 0.0014
279 BODY HEIGHT DECREASED 15 0.0014
280 ALCOHOLISM 6 0.0014
281 LOW BIRTH WEIGHT BABY 11 0.0014
282 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
283 BILIARY COLIC 4 0.0014
284 RESTLESS LEGS SYNDROME 25 0.0014
285 SPINAL PAIN 16 0.0014
286 THROMBOCYTOSIS 5 0.0014
287 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
288 LYMPHOCYTE COUNT DECREASED 24 0.0014
289 LIMB DISCOMFORT 42 0.0014
290 FACIAL PAIN 12 0.0013
291 MATERNAL EXPOSURE TIMING UNSPECIFIED 5 0.0013
292 MENSTRUAL DISORDER 11 0.0013
293 FOETAL GROWTH RESTRICTION 8 0.0013
294 GINGIVAL DISORDER 5 0.0013
295 BLOOD PRESSURE FLUCTUATION 31 0.0013
296 DEFORMITY 12 0.0013
297 SUBARACHNOID HAEMORRHAGE 13 0.0013
298 NAIL DISCOLOURATION 5 0.0013
299 PLEURAL EFFUSION 77 0.0013
300 POLYDIPSIA 5 0.0013
301 FEAR OF INJECTION 9 0.0013
302 GESTATIONAL DIABETES 6 0.0013
303 INTRACRANIAL PRESSURE INCREASED 7 0.0013
304 BLINDNESS 51 0.0013
305 BLOOD TRIGLYCERIDES INCREASED 22 0.0012
306 CHOLECYSTITIS ACUTE 7 0.0012
307 MUSCLE DISORDER 10 0.0012
308 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
309 BREAST PAIN 13 0.0012
310 DEMENTIA 34 0.0012
311 HYPOGLYCAEMIA 59 0.0012
312 RALES 7 0.0012
313 CAESAREAN SECTION 14 0.0012
314 HEART RATE IRREGULAR 27 0.0012
315 HEAD DISCOMFORT 21 0.0012
316 BRADYKINESIA 7 0.0012
317 BUNDLE BRANCH BLOCK LEFT 5 0.0012
318 HYPOPHAGIA 30 0.0012
319 INCREASED UPPER AIRWAY SECRETION 6 0.0012
320 LUNG NEOPLASM MALIGNANT 48 0.0012
321 INFLAMMATION 60 0.0012
322 ORAL PAIN 26 0.0012
323 HAEMATOCRIT DECREASED 23 0.0012
324 FAECES DISCOLOURED 25 0.0012
325 MALABSORPTION 6 0.0011
326 AORTIC STENOSIS 4 0.0011
327 MASS 16 0.0011
328 AFFECT LABILITY 11 0.0011
329 HEART RATE DECREASED 40 0.0011
330 DEPRESSIVE SYMPTOM 4 0.0011
331 RENAL CYST 9 0.0011
332 RHINITIS 9 0.0011
333 URINARY INCONTINENCE 33 0.0011
334 MUCOSAL INFLAMMATION 29 0.0011
335 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
336 FAECALOMA 6 0.0011
337 MANIA 18 0.0011
338 ALCOHOL USE 4 0.0011
339 EATING DISORDER 23 0.0011
340 EAR DISCOMFORT 11 0.0011
341 SPINAL DISORDER 10 0.0011
342 CARDIAC FAILURE ACUTE 7 0.0010
343 ABDOMINAL DISCOMFORT 176 0.0010
344 SKIN HYPERPIGMENTATION 9 0.0010
345 MATERNAL EXPOSURE DURING PREGNANCY 93 0.0010
346 PULMONARY FIBROSIS 20 0.0010
347 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
348 HERPES VIRUS INFECTION 6 0.0010
349 DIABETES MELLITUS 79 0.0010
350 METABOLIC DISORDER 6 0.0010
351 BLOOD POTASSIUM DECREASED 31 0.0010
352 PSYCHOMOTOR HYPERACTIVITY 17 0.0010
353 RED BLOOD CELL COUNT DECREASED 29 0.0010
354 BIPOLAR DISORDER 11 0.0010
355 LIGAMENT SPRAIN 10 0.0010
356 FURUNCLE 8 0.0010
357 DYSKINESIA 41 0.0010
358 BLOOD GLUCOSE FLUCTUATION 11 0.0010
359 CEREBRAL ATROPHY 4 0.0010
360 INJECTION SITE INDURATION 13 0.0010
361 FOREIGN BODY 4 0.0010
362 INJECTION SITE VESICLES 6 0.0010
363 BONE DISORDER 18 0.0010
364 INGUINAL HERNIA 6 0.0010
365 PARANOIA 17 0.0010
366 PSYCHOTIC DISORDER 29 0.0010
367 ABNORMAL FAECES 8 0.0010
368 PRODUCT COLOUR ISSUE 5 0.0010
369 PRE-EXISTING CONDITION IMPROVED 6 0.0010
370 CONGESTIVE CARDIOMYOPATHY 4 0.0010
371 BLEPHAROSPASM 6 0.0010
372 HYPOTHYROIDISM 30 0.0009
373 PREMATURE BABY 28 0.0009
374 DIZZINESS POSTURAL 9 0.0009
375 DYSTONIA 18 0.0009
376 DECREASED ACTIVITY 10 0.0009
377 DEPRESSED MOOD 49 0.0009
378 MUSCLE STRAIN 8 0.0009
379 ABORTION SPONTANEOUS 37 0.0009
380 PARKINSONISM 9 0.0009
381 OSTEOARTHRITIS 39 0.0009
382 BRADYPHRENIA 6 0.0009
383 DRUG INTERACTION 145 0.0009
384 MATERNAL DRUGS AFFECTING FOETUS 7 0.0009
385 DYSGRAPHIA 6 0.0009
386 OSTEOPOROSIS 37 0.0009
387 HEART RATE ABNORMAL 5 0.0009
388 HAEMOLYTIC ANAEMIA 8 0.0009
389 PRODUCT ADMINISTRATION ERROR 18 0.0009
390 HALLUCINATION 67 0.0009
391 HEAD INJURY 28 0.0009
392 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
393 MATERNAL EXPOSURE BEFORE PREGNANCY 6 0.0009
394 EYE MOVEMENT DISORDER 6 0.0009
395 BLOOD GLUCOSE DECREASED 42 0.0009
396 DISEASE COMPLICATION 4 0.0009
397 SENSORY LOSS 7 0.0009
398 MOUTH SWELLING 5 0.0009
399 HYPERVENTILATION 5 0.0009
400 PERSONALITY CHANGE 8 0.0009
401 EXTRASYSTOLES 6 0.0009
402 FLANK PAIN 8 0.0009
403 ENERGY INCREASED 5 0.0008
404 NIGHTMARE 29 0.0008
405 HEARING IMPAIRED 5 0.0008
406 APHAGIA 4 0.0008
407 BLOOD PRESSURE INCREASED 126 0.0008
408 TENSION 5 0.0008
409 DRUG INTOLERANCE 79 0.0008
410 BLOOD PRESSURE DECREASED 54 0.0008
411 VENTRICULAR FIBRILLATION 9 0.0008
412 ABNORMAL BEHAVIOUR 32 0.0008
413 THINKING ABNORMAL 15 0.0008
414 ORTHOSTATIC HYPOTENSION 14 0.0008
415 REBOUND EFFECT 9 0.0008
416 OSTEOPENIA 12 0.0008
417 BALANCE DISORDER 68 0.0008
418 THERAPEUTIC PRODUCT EFFECT DECREASED 35 0.0008
419 MOVEMENT DISORDER 25 0.0008
420 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
421 CONGENITAL ANOMALY 6 0.0008
422 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
423 MOOD ALTERED 21 0.0008
424 HAEMORRHAGIC STROKE 6 0.0008
425 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
426 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
427 PNEUMONIA ASPIRATION 19 0.0008
428 HYPERTHYROIDISM 11 0.0008
429 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
430 IRON DEFICIENCY ANAEMIA 7 0.0008
431 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
432 NERVOUSNESS 39 0.0007
433 TYPE 2 DIABETES MELLITUS 25 0.0007
434 ERECTILE DYSFUNCTION 19 0.0007
435 SKIN DISCOLOURATION 34 0.0007
436 BLOOD URINE PRESENT 14 0.0007
437 PERICARDIAL EFFUSION 17 0.0007
438 AUTISM SPECTRUM DISORDER 4 0.0007
439 DEAFNESS UNILATERAL 4 0.0007
440 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
441 CYST 9 0.0007
442 HERNIA 14 0.0007
443 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16 0.0007
444 EAR PAIN 14 0.0007
445 DYSPNOEA EXERTIONAL 27 0.0007
446 ACUTE PULMONARY OEDEMA 4 0.0007
447 OCULAR DISCOMFORT 8 0.0007
448 TENDONITIS 11 0.0007
449 NEUTROPENIC SEPSIS 5 0.0007
450 ANGINA PECTORIS 20 0.0007
451 CARDIAC FAILURE 56 0.0007
452 PANIC REACTION 5 0.0007
453 PREMATURE DELIVERY 11 0.0007
454 UTERINE LEIOMYOMA 5 0.0007
455 PULMONARY CONGESTION 9 0.0007
456 PERIPHERAL SWELLING 105 0.0007
457 LUNG INFILTRATION 6 0.0007
458 LABORATORY TEST ABNORMAL 20 0.0007
459 STEVENS-JOHNSON SYNDROME 15 0.0007
460 FEELING DRUNK 5 0.0007
461 MEMORY IMPAIRMENT 92 0.0007
462 MYOSITIS 6 0.0007
463 DERMATITIS 14 0.0007
464 GANGRENE 4 0.0007
465 DELIRIUM 23 0.0007
466 MENORRHAGIA 13 0.0007
467 LETHARGY 38 0.0007
468 ECONOMIC PROBLEM 10 0.0007
469 AGGRESSION 33 0.0007
470 TREATMENT NONCOMPLIANCE 36 0.0007
471 PERIPHERAL COLDNESS 9 0.0007
472 JOINT INJURY 14 0.0007
473 DRUG DISPENSING ERROR 10 0.0007
474 INJECTION SITE MASS 24 0.0006
475 APHTHOUS ULCER 5 0.0006
476 SQUAMOUS CELL CARCINOMA 6 0.0006
477 INJECTION SITE NODULE 7 0.0006
478 AFFECTIVE DISORDER 5 0.0006
479 DENTAL CARIES 7 0.0006
480 FOOT DEFORMITY 7 0.0006
481 GAIT INABILITY 21 0.0006
482 AMENORRHOEA 11 0.0006
483 MALNUTRITION 7 0.0006
484 SENSORY DISTURBANCE 10 0.0006
485 ANGER 21 0.0006
486 HYPOKINESIA 9 0.0006
487 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
488 INTERSTITIAL LUNG DISEASE 30 0.0006
489 APATHY 9 0.0006
490 GALLBLADDER DISORDER 11 0.0006
491 MUSCULOSKELETAL PAIN 32 0.0006
492 POLYURIA 5 0.0006
493 ACUTE MYOCARDIAL INFARCTION 18 0.0006
494 PRODUCT DOSE OMISSION ISSUE 179 0.0006
495 SECOND PRIMARY MALIGNANCY 5 0.0006
496 GAIT DISTURBANCE 115 0.0006
497 CONFUSIONAL STATE 97 0.0006
498 LIVE BIRTH 5 0.0006
499 COLITIS ISCHAEMIC 4 0.0006
500 EYELID PTOSIS 6 0.0006
501 ECCHYMOSIS 4 0.0006
502 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
503 ANXIETY 165 0.0006
504 CONDITION AGGRAVATED 176 0.0006
505 ENCEPHALITIS 4 0.0006
506 HYSTERECTOMY 5 0.0006
507 PYELONEPHRITIS 5 0.0006
508 BRAIN FOG 9 0.0006
509 WEIGHT FLUCTUATION 6 0.0006
510 APHONIA 8 0.0006
511 DYSURIA 21 0.0006
512 JOINT DISLOCATION 6 0.0006
513 SUDDEN DEATH 6 0.0006
514 OEDEMA PERIPHERAL 69 0.0006
515 OVERDOSE 121 0.0006
516 PARALYSIS 8 0.0006
517 DRUG EXPOSURE DURING PREGNANCY 19 0.0006
518 DISEASE PROGRESSION 66 0.0006
519 BLOOD CHOLESTEROL INCREASED 26 0.0006
520 ANAL INCONTINENCE 5 0.0006
521 HEAVY MENSTRUAL BLEEDING 5 0.0006
522 ABDOMINAL PAIN LOWER 14 0.0006
523 OROPHARYNGEAL DISCOMFORT 5 0.0006
524 BACK DISORDER 9 0.0006
525 BLOOD PRESSURE ABNORMAL 11 0.0006
526 ANOSMIA 8 0.0006
527 CRYING 20 0.0005
528 ARRHYTHMIA 26 0.0005
529 HEADACHE 344 0.0005
530 EXOSTOSIS 5 0.0005
531 EXPOSURE DURING PREGNANCY 34 0.0005
532 MUSCULAR WEAKNESS 62 0.0005
533 ABDOMINAL PAIN UPPER 112 0.0005
534 ILLNESS 56 0.0005
535 TASTE DISORDER 11 0.0005
536 RHINORRHOEA 35 0.0005
537 VERTIGO 33 0.0005
538 BLOOD GLUCOSE ABNORMAL 10 0.0005
539 CEREBRAL DISORDER 4 0.0005
540 SLEEP DISORDER 38 0.0005
541 MENTAL IMPAIRMENT 13 0.0005
542 HYPERHIDROSIS 69 0.0005
543 SKIN INFECTION 6 0.0005
544 ABORTION INDUCED 5 0.0005
545 BLOOD SODIUM DECREASED 10 0.0005
546 BONE PAIN 31 0.0005
547 METRORRHAGIA 9 0.0005
548 HAEMATOTOXICITY 5 0.0005
549 SCAB 6 0.0005
550 HAEMATURIA 18 0.0005
551 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
552 WEIGHT DECREASED 145 0.0005
553 GLAUCOMA 10 0.0005
554 ATELECTASIS 5 0.0005
555 MUSCULOSKELETAL CHEST PAIN 8 0.0005
556 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 93 0.0005
557 SPEECH DISORDER 27 0.0005
558 HYPERTENSION 109 0.0005
559 PULMONARY OEDEMA 23 0.0005
560 COVID-19 90 0.0005
561 VITAMIN D DEFICIENCY 5 0.0005
562 VISUAL ACUITY REDUCED 17 0.0005
563 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
564 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
565 VISUAL IMPAIRMENT 63 0.0005
566 VAGINAL HAEMORRHAGE 22 0.0005
567 DISORIENTATION 20 0.0005
568 PNEUMOTHORAX 8 0.0005
569 MEDICATION ERROR 28 0.0005
570 CHOLECYSTITIS 6 0.0005
571 ULCER 8 0.0005
572 OVARIAN CYST 5 0.0005
573 SALIVARY HYPERSECRETION 5 0.0005
574 APPLICATION SITE PAIN 11 0.0005
575 BURSITIS 6 0.0005
576 DRY THROAT 5 0.0005
577 MOTOR DYSFUNCTION 5 0.0005
578 BRONCHOSPASM 7 0.0005
579 MALAISE 215 0.0005
580 BLOOD CREATININE INCREASED 32 0.0005
581 EUPHORIC MOOD 5 0.0005
582 CARDIOGENIC SHOCK 7 0.0005
583 SOMNOLENCE 97 0.0005
584 DIZZINESS 240 0.0005
585 RASH ERYTHEMATOUS 23 0.0005
586 TENDERNESS 5 0.0005
587 DYSARTHRIA 18 0.0005
588 ROAD TRAFFIC ACCIDENT 20 0.0005
589 NASAL CONGESTION 28 0.0005
590 FRACTURE 9 0.0005
591 SKIN LESION 13 0.0005
592 CARDIOMYOPATHY 7 0.0005
593 INCONTINENCE 5 0.0005
594 IMMUNODEFICIENCY 7 0.0005
595 HYPOAESTHESIA 70 0.0005
596 FOETAL EXPOSURE DURING PREGNANCY 38 0.0005
597 THERAPY NON-RESPONDER 21 0.0005
598 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
599 PANIC ATTACK 17 0.0005
600 FALL 155 0.0005
601 ANOREXIA 6 0.0005
602 NECK PAIN 26 0.0005
603 MUSCULOSKELETAL DISCOMFORT 8 0.0005
604 HOT FLUSH 35 0.0005
605 DYSPHAGIA 44 0.0005
606 DISTURBANCE IN ATTENTION 25 0.0005
607 PRODUCT PRESCRIBING ERROR 11 0.0005
608 OEDEMA 25 0.0005
609 BACK INJURY 5 0.0005
610 PRODUCT DISPENSING ERROR 10 0.0005
611 NEPHROLITHIASIS 21 0.0005
612 PARAESTHESIA 72 0.0005
613 HAND DEFORMITY 6 0.0005
614 ASPIRATION 5 0.0005
615 POLLAKIURIA 19 0.0005
616 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
617 DYSMENORRHOEA 6 0.0005
618 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
619 DECREASED APPETITE 105 0.0005
620 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
621 ABDOMINAL PAIN 105 0.0005
622 OFF LABEL USE 391 0.0004
623 FEELING ABNORMAL 107 0.0004
624 PANCREATITIS ACUTE 10 0.0004
625 SINUS CONGESTION 6 0.0004
626 BODY TEMPERATURE INCREASED 9 0.0004
627 ABDOMINAL DISTENSION 46 0.0004
628 PELVIC PAIN 8 0.0004
629 MOOD SWINGS 14 0.0004
630 TINNITUS 20 0.0004
631 BLOOD GLUCOSE INCREASED 82 0.0004
632 DEPRESSION 99 0.0004
633 CHRONIC KIDNEY DISEASE 33 0.0004
634 TOOTH LOSS 9 0.0004
635 IRRITABILITY 26 0.0004
636 MADAROSIS 5 0.0004
637 SYNCOPE 43 0.0004
638 THERAPEUTIC RESPONSE DECREASED 26 0.0004
639 CARPAL TUNNEL SYNDROME 6 0.0004
640 MIDDLE INSOMNIA 8 0.0004
641 BLOOD TEST ABNORMAL 6 0.0004
642 METASTASES TO BONE 7 0.0004
643 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
644 CONTUSION 41 0.0004
645 EYE DISORDER 14 0.0004
646 HAEMATOMA 11 0.0004
647 VENTRICULAR TACHYCARDIA 7 0.0004
648 SINUS TACHYCARDIA 6 0.0004
649 RASH 184 0.0004
650 EMOTIONAL DISORDER 13 0.0004
651 CHEST PAIN 78 0.0004
652 DISEASE RECURRENCE 20 0.0004
653 EYE INFLAMMATION 4 0.0004
654 SUBDURAL HAEMATOMA 6 0.0004
655 INCREASED APPETITE 8 0.0004
656 POOR QUALITY SLEEP 9 0.0004
657 POST PROCEDURAL COMPLICATION 8 0.0004
658 WEIGHT INCREASED 93 0.0004
659 FACE OEDEMA 7 0.0004
660 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
661 HYPOKALAEMIA 19 0.0004
662 HAEMORRHOIDS 8 0.0004
663 NO THERAPEUTIC RESPONSE 5 0.0004
664 FEAR 11 0.0004
665 DRUG EFFECT DECREASED 22 0.0004
666 KIDNEY INFECTION 8 0.0004
667 ABASIA 10 0.0004
668 PAIN IN EXTREMITY 119 0.0004
669 PHARYNGITIS 5 0.0004
670 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
671 ILEUS 5 0.0004
672 AMNESIA 26 0.0004
673 SECRETION DISCHARGE 5 0.0004
674 METASTASES TO LIVER 7 0.0004
675 EMPHYSEMA 4 0.0004
676 BRAIN OEDEMA 5 0.0004
677 HYPOACUSIS 17 0.0004
678 HEART RATE INCREASED 39 0.0004
679 WOUND 11 0.0004
680 SUICIDAL IDEATION 36 0.0004
681 HIP ARTHROPLASTY 6 0.0004
682 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
683 CONSTIPATION 85 0.0004
684 GENERAL PHYSICAL HEALTH DETERIORATION 45 0.0004
685 DIPLOPIA 10 0.0004
686 LIVER DISORDER 17 0.0004
687 HAEMOGLOBIN DECREASED 39 0.0004
688 BACK PAIN 88 0.0004
689 DYSSTASIA 11 0.0004
690 IMPAIRED WORK ABILITY 8 0.0004
691 FATIGUE 290 0.0004
692 EYE PAIN 21 0.0004
693 SINUSITIS 38 0.0004
694 NEURALGIA 9 0.0004
695 NAUSEA 291 0.0004
696 ALOPECIA 72 0.0004
697 AKATHISIA 5 0.0004
698 JOINT SWELLING 44 0.0004
699 SEROTONIN SYNDROME 7 0.0004
700 ASTHENIA 137 0.0004
701 DRUG PRESCRIBING ERROR 7 0.0004
702 VIRAL INFECTION 12 0.0004
703 WHITE BLOOD CELL COUNT DECREASED 39 0.0004
704 HYPOMAGNESAEMIA 5 0.0004
705 INFLUENZA 40 0.0004
706 COORDINATION ABNORMAL 5 0.0004
707 ANAEMIA 68 0.0004
708 PRODUCTIVE COUGH 17 0.0004
709 BLOOD CALCIUM DECREASED 4 0.0004
710 HAEMATEMESIS 9 0.0004
711 BLINDNESS UNILATERAL 5 0.0004
712 CHROMATURIA 8 0.0004
713 MUSCLE SPASMS 65 0.0004
714 AGITATION 26 0.0004
715 SINUS DISORDER 7 0.0004
716 INSOMNIA 94 0.0004
717 DERMATITIS CONTACT 4 0.0004
718 VISION BLURRED 48 0.0003
719 EYE SWELLING 13 0.0003
720 SPINAL FRACTURE 7 0.0003
721 ANAPHYLACTIC SHOCK 9 0.0003
722 SHOCK 8 0.0003
723 IMPAIRED QUALITY OF LIFE 5 0.0003
724 PRODUCT SUBSTITUTION ISSUE 20 0.0003
725 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
726 INJECTION SITE HAEMATOMA 5 0.0003
727 DEAFNESS 9 0.0003
728 TREMOR 57 0.0003
729 BURNING SENSATION 24 0.0003
730 DYSPHONIA 20 0.0003
731 SWELLING 32 0.0003
732 COLD SWEAT 6 0.0003
733 INJECTION SITE WARMTH 7 0.0003
734 ASCITES 10 0.0003
735 DRUG ERUPTION 6 0.0003
736 SWELLING FACE 22 0.0003
737 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 24 0.0003
738 NEUROPATHY PERIPHERAL 32 0.0003
739 VOMITING 158 0.0003
740 COMA 16 0.0003
741 MYALGIA 57 0.0003
742 OROPHARYNGEAL PAIN 31 0.0003
743 FREQUENT BOWEL MOVEMENTS 9 0.0003
744 PALPITATIONS 39 0.0003
745 BONE LOSS 5 0.0003
746 INJECTION SITE PAIN 102 0.0003
747 PNEUMONITIS 9 0.0003
748 C-REACTIVE PROTEIN INCREASED 12 0.0003
749 FIBROMYALGIA 8 0.0003
750 PRESYNCOPE 8 0.0003
751 RESPIRATORY ARREST 9 0.0003
752 PULMONARY EMBOLISM 31 0.0003
753 PAIN 200 0.0003
754 MIGRAINE 31 0.0003
755 SURGERY 19 0.0003
756 GASTROINTESTINAL DISORDER 29 0.0003
757 CONJUNCTIVITIS 6 0.0003
758 EJECTION FRACTION DECREASED 5 0.0003
759 HEPATIC FUNCTION ABNORMAL 12 0.0003
760 CARDIAC DISORDER 30 0.0003
761 BRADYCARDIA 17 0.0003
762 MUSCULOSKELETAL STIFFNESS 28 0.0003
763 PRODUCT USE IN UNAPPROVED INDICATION 79 0.0003
764 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
765 TACHYCARDIA 28 0.0003
766 ARTHRALGIA 131 0.0003
767 TOOTH DISORDER 7 0.0003
768 FLUID RETENTION 16 0.0003
769 SCIATICA 5 0.0003
770 INJECTION SITE SWELLING 24 0.0003
771 NIGHT SWEATS 10 0.0003
772 NASOPHARYNGITIS 57 0.0003
773 HYPOTENSION 62 0.0003
774 DRUG INEFFECTIVE 407 0.0003
775 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
776 DEEP VEIN THROMBOSIS 20 0.0003
777 ANHEDONIA 8 0.0003
778 LOSS OF CONSCIOUSNESS 39 0.0003
779 GASTRITIS 8 0.0003
780 RESPIRATORY FAILURE 22 0.0003
781 ERYTHEMA 62 0.0003
782 FLATULENCE 17 0.0003
783 PREGNANCY 6 0.0003
784 MENTAL DISORDER 13 0.0003
785 THROMBOSIS 24 0.0003
786 APHASIA 9 0.0003
787 PERICARDITIS 5 0.0003
788 INTENTIONAL SELF-INJURY 6 0.0003
789 SUICIDE ATTEMPT 18 0.0003
790 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
791 DIARRHOEA 191 0.0003
792 HEMIPARESIS 5 0.0003
793 DISCOMFORT 18 0.0003
794 DRUG DEPENDENCE 47 0.0003
795 DRY SKIN 39 0.0003
796 RIB FRACTURE 6 0.0003
797 CORONARY ARTERY OCCLUSION 4 0.0003
798 THROAT IRRITATION 13 0.0003
799 SWOLLEN TONGUE 9 0.0003
800 FEELING COLD 8 0.0003
801 SYRINGE ISSUE 5 0.0003
802 DRY MOUTH 23 0.0003
803 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
804 MOBILITY DECREASED 20 0.0003
805 COUGH 78 0.0003
806 FEELING HOT 17 0.0003
807 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
808 LEUKOCYTOSIS 5 0.0003
809 GASTROENTERITIS 4 0.0003
810 URINARY TRACT INFECTION 46 0.0003
811 HYPERSENSITIVITY 50 0.0003
812 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 19 0.0003
813 JOINT STIFFNESS 7 0.0003
814 CARDIAC ARREST 22 0.0003
815 INJECTION SITE ERYTHEMA 33 0.0003
816 PHOTOPHOBIA 5 0.0003
817 RHABDOMYOLYSIS 11 0.0003
818 PRODUCT AVAILABILITY ISSUE 6 0.0003
819 EPILEPSY 8 0.0003
820 JAUNDICE 7 0.0003
821 LEUKOPENIA 13 0.0003
822 SEIZURE 30 0.0003
823 THROMBOCYTOPENIA 29 0.0003
824 ANKLE FRACTURE 4 0.0003
825 PRESCRIBED OVERDOSE 5 0.0003
826 FEMUR FRACTURE 8 0.0003
827 LIMB INJURY 7 0.0003
828 ACUTE MYELOID LEUKAEMIA 4 0.0003
829 NERVOUS SYSTEM DISORDER 8 0.0003
830 CHILLS 30 0.0003
831 LYMPHADENOPATHY 9 0.0003
832 ABNORMAL DREAMS 7 0.0003
833 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
834 CATARACT 15 0.0003
835 HAEMOPTYSIS 7 0.0003
836 BLISTER 14 0.0002
837 HAEMORRHAGE 26 0.0002
838 CEREBRAL INFARCTION 6 0.0002
839 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
840 EXPIRED PRODUCT ADMINISTERED 8 0.0002
841 LIP SWELLING 8 0.0002
842 DEHYDRATION 32 0.0002
843 SKIN DISORDER 8 0.0002
844 URINARY RETENTION 8 0.0002
845 PRODUCT USE ISSUE 45 0.0002
846 PRURITUS 92 0.0002
847 UNEVALUABLE EVENT 18 0.0002
848 CARDIOVASCULAR DISORDER 6 0.0002
849 COGNITIVE DISORDER 11 0.0002
850 HEPATITIS 6 0.0002
851 RECTAL HAEMORRHAGE 10 0.0002
852 STOMATITIS 14 0.0002
853 ARTHRITIS 18 0.0002
854 PYREXIA 79 0.0002
855 INTENTIONAL PRODUCT USE ISSUE 20 0.0002
856 HYPERKALAEMIA 8 0.0002
857 DYSPNOEA 129 0.0002
858 INJECTION SITE BRUISING 18 0.0002
859 EAR INFECTION 6 0.0002
860 TRANSAMINASES INCREASED 5 0.0002
861 RASH MACULO-PAPULAR 5 0.0002
862 MENSTRUATION IRREGULAR 6 0.0002
863 DYSPEPSIA 22 0.0002
864 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
865 DRUG-INDUCED LIVER INJURY 7 0.0002
866 BLOOD BILIRUBIN INCREASED 6 0.0002
867 GASTROENTERITIS VIRAL 4 0.0002
868 RESTLESSNESS 8 0.0002
869 MUSCLE TWITCHING 5 0.0002
870 DIVERTICULITIS 6 0.0002
871 PROCEDURAL PAIN 6 0.0002
872 CHEST DISCOMFORT 22 0.0002
873 ACNE 16 0.0002
874 FOOT FRACTURE 4 0.0002
875 GASTRIC ULCER 4 0.0002
876 FUNGAL INFECTION 7 0.0002
877 FEELING JITTERY 4 0.0002
878 HYPERSOMNIA 6 0.0002
879 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
880 SEPTIC SHOCK 9 0.0002
881 EMOTIONAL DISTRESS 25 0.0002
882 CHOKING 4 0.0002
883 BRONCHITIS 15 0.0002
884 EXTRAPYRAMIDAL DISORDER 5 0.0002
885 EPISTAXIS 15 0.0002
886 AGEUSIA 5 0.0002
887 ADVERSE DRUG REACTION 18 0.0002
888 CARDIAC FAILURE CONGESTIVE 16 0.0002
889 PRODUCT DOSE OMISSION 13 0.0002
890 PRODUCT QUALITY ISSUE 27 0.0002
891 HYPOXIA 7 0.0002
892 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
893 FEEDING DISORDER 4 0.0002
894 URTICARIA 33 0.0002
895 PANCYTOPENIA 11 0.0002
896 RENAL FAILURE 26 0.0002
897 INFLUENZA LIKE ILLNESS 16 0.0002
898 GYNAECOMASTIA 6 0.0002
899 DRUG EFFECT INCOMPLETE 7 0.0002
900 SEDATION 5 0.0002
901 PANCREATITIS 10 0.0002
902 INJECTION SITE REACTION 13 0.0002
903 DYSGEUSIA 14 0.0002
904 WHEEZING 11 0.0002
905 PALLOR 5 0.0002
906 OSTEONECROSIS 6 0.0002
907 MENTAL STATUS CHANGES 5 0.0002
908 GLOSSODYNIA 4 0.0002
909 EYE PRURITUS 6 0.0002
910 PLATELET COUNT DECREASED 19 0.0002
911 OXYGEN SATURATION DECREASED 10 0.0002
912 HEPATIC ENZYME INCREASED 12 0.0002
913 INTENTIONAL DOSE OMISSION 5 0.0002
914 INJECTION SITE HAEMORRHAGE 14 0.0002
915 CONVULSION 10 0.0002
916 PNEUMONIA 56 0.0002
917 INJURY 12 0.0002
918 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
919 TREATMENT FAILURE 14 0.0002
920 WITHDRAWAL SYNDROME 7 0.0002
921 DIABETIC KETOACIDOSIS 4 0.0002
922 HEPATIC FAILURE 5 0.0002
923 NEOPLASM MALIGNANT 11 0.0002
924 INJECTION SITE PRURITUS 11 0.0002
925 LUNG DISORDER 8 0.0002
926 DRY EYE 8 0.0002
927 HYPONATRAEMIA 9 0.0002
928 INTESTINAL OBSTRUCTION 6 0.0002
929 FLUSHING 16 0.0002
930 CYSTITIS 5 0.0002
931 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
932 HIP FRACTURE 5 0.0002
933 SKIN EXFOLIATION 13 0.0002
934 CEREBROVASCULAR ACCIDENT 26 0.0002
935 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
936 UNDERDOSE 11 0.0002
937 RENAL DISORDER 7 0.0002
938 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
939 GASTRIC DISORDER 5 0.0001
940 CARDIO-RESPIRATORY ARREST 6 0.0001
941 RASH MACULAR 5 0.0001
942 ASTHMA 16 0.0001
943 NEUTROPENIA 19 0.0001
944 CEREBRAL HAEMORRHAGE 5 0.0001
945 EYE IRRITATION 8 0.0001
946 PROSTATE CANCER 11 0.0001
947 ATRIAL FIBRILLATION 13 0.0001
948 CORONARY ARTERY DISEASE 4 0.0001
949 DRUG ADMINISTRATION ERROR 4 0.0001
950 INCORRECT DOSE ADMINISTERED 29 0.0001
951 HAEMATOCHEZIA 7 0.0001
952 THERAPY INTERRUPTED 9 0.0001
953 SEPSIS 14 0.0001
954 INTENTIONAL OVERDOSE 8 0.0001
955 ACUTE KIDNEY INJURY 19 0.0001
956 DRUG DOSE OMISSION 20 0.0001
957 PSORIASIS 15 0.0001
958 ANGIOEDEMA 5 0.0001
959 INFECTION 16 0.0001
960 ACCIDENTAL OVERDOSE 4 0.0001
961 SKIN IRRITATION 5 0.0001
962 BREAST CANCER 10 0.0001
963 RENAL IMPAIRMENT 9 0.0001
964 COLITIS 4 0.0001
965 OCULAR HYPERAEMIA 5 0.0001
966 MULTIPLE SCLEROSIS 5 0.0001
967 MYOCARDIAL INFARCTION 18 0.0001
968 PRODUCT STORAGE ERROR 9 0.0001
969 NO ADVERSE EVENT 18 0.0001
970 ILL-DEFINED DISORDER 6 0.0001
971 SKIN BURNING SENSATION 7 0.0001
972 ADVERSE EVENT 9 0.0001
973 DERMATITIS ATOPIC 5 0.0001
974 DEVICE EXPULSION 6 0.0001
975 DEVICE DISLOCATION 4 0.0001
976 DEPENDENCE 5 0.0001
977 HOSPITALISATION 14 0.0001
978 FEBRILE NEUTROPENIA 6 0.0001
979 COLITIS ULCERATIVE 4 0.0001
980 DEVICE ISSUE 8 0.0001
981 TOXICITY TO VARIOUS AGENTS 15 0.0001
982 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
984 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
985 ECZEMA 4 0.0001
986 DRUG DOSE OMISSION BY DEVICE 5 0.0001
987 DEATH 42 0.0000
988 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
989 RHEUMATOID ARTHRITIS 5 0.0000
990 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000